möglich sobald bei der ZB eingereicht worden ist.
Mitochondrial glutathione peroxidase 4 disruption causes male infertility.
FASEB J. 23, 3233-3242 (2009)
Selenium is linked to male fertility. Glutathione peroxidase 4 (GPx4), first described as an antioxidant enzyme, is the predominant selenoenzyme in testis and has been suspected of being vital for spermatogenesis. Cytosolic, mitochondrial, and nuclear isoforms are all encoded by the same gene. While disruption of entire GPx4 causes early embryonic lethality in mice, inactivation of nuclear GPx4 does not impair embryonic development or fertility. Here, we show that deletion of mitochondrial GPx4 (mGPx4) allows both normal embryogenesis and postnatal development, but causes male infertility. Infertility was associated with impaired sperm quality and severe structural abnormalities in the midpiece of spermatozoa. Knockout sperm display higher protein thiol content and recapitulate features typical of severe selenodeficiency. Interestingly, male infertility induced by mGPx4 depletion could be bypassed by intracytoplasmic sperm injection. We also show for the first time that mGPx4 is the prevailing GPx4 product in male germ cells and that mGPx4 disruption has no effect on proliferation or apoptosis of germinal or somatic tissue. Our study finally establishes that mitochondrial GPx4 confers the vital role of selenium in mammalian male fertility and identifies cytosolic GPx4 as the only GPx4 isoform being essential for embryonic development and apoptosis regulation.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
7.049
1.610
106
215
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
PHGPx; redox metabolism; selenoprotein; spermatogenesis
Sprache
englisch
Veröffentlichungsjahr
2009
HGF-Berichtsjahr
2009
ISSN (print) / ISBN
0892-6638
e-ISSN
1530-6860
Zeitschrift
FASEB Journal
Quellenangaben
Band: 23,
Heft: 9,
Seiten: 3233-3242
Verlag
Wiley
Verlagsort
Bethesda, Md.
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Clinical Molecular Biology and Tumor Genetics (K.MOLBI)
Institute of Developmental Genetics (IDG)
Institute of Pathology (PATH)
Institute of Experimental Genetics (IEG)
Research Unit Gene Vector (AGV)
Research Unit Analytical Pathology (AAP)
Institute of Developmental Genetics (IDG)
Institute of Pathology (PATH)
Institute of Experimental Genetics (IEG)
Research Unit Gene Vector (AGV)
Research Unit Analytical Pathology (AAP)
POF Topic(s)
30204 - Cell Programming and Repair
30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
30201 - Metabolic Health
30203 - Molecular Targets and Therapies
30205 - Bioengineering and Digital Health
30204 - Cell Programming and Repair
30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
30201 - Metabolic Health
30203 - Molecular Targets and Therapies
30205 - Bioengineering and Digital Health
Forschungsfeld(er)
Genetics and Epidemiology
Enabling and Novel Technologies
Immune Response and Infection
Genetics and Epidemiology
Enabling and Novel Technologies
Immune Response and Infection
PSP-Element(e)
G-501400-003
G-500500-001
G-500300-001
G-500600-003
G-501500-001
G-500390-001
G-500500-001
G-500300-001
G-500600-003
G-501500-001
G-500390-001
PubMed ID
19417079
Scopus ID
70349326728
Erfassungsdatum
2009-09-09